Cva Family Office, LLC Novavax Inc Transaction History

Cva Family Office, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 25, 2022	SELL	$134.56 - $217.97 $1,883 - $3,051	-14 Closed	0 $0
Q3 2021 Oct 12, 2021	BUY	$177.8 - $270.58 $2,489 - $3,788	14 New	14 $2,000
Q4 2020 Jan 15, 2021	SELL	$78.74 - $139.5 $1,102 - $1,953	-14 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$13.86 - $83.61 $194 - $1,170	14 New	14 $1,000

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Cva Family Office, LLC, based on Form 13F filings with the SEC.

Stay updated on Cva Family Office, LLC with notifications on news.